Health-related QOL in acute exacerbations of chronic bronchitis and chronic obstructive pulmonary disease: A review of the literature

PharmacoEconomics

Volumn 23, Issue 4, 2005, Pages 345-363

  Doll, Helen ^a   Miravitlles, Marc ^b  

^a ICON PLC   (United Kingdom)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BASELINE AND TRANSITIONAL DYSPNEA INDEX; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY DISEASE QUESTIONNAIRE; DISEASE EXACERBATION; FUNCTIONAL ASSESSMENT; HOSPITAL ADMISSION; HUMAN; INSTRUMENT; MEDICAL LITERATURE; MORTALITY; OUTCOMES RESEARCH; PATIENT CODING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REVIEW; SAINT GEORGE RESPIRATORY QUESTIONNAIRE; SYMPTOMATOLOGY;

ANIMALS; BRONCHITIS, CHRONIC; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE;

EID: 18744371291     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-200523040-00005     Document Type: Review

References (105)

1. Ball P, Harris JM, Lowson D, et al. Acute infective exacerbations of chronic bronchitis. Q J Med 1995; 88: 61-8
2. Seemungal TAR, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 1418-22
3. Miravitlles M, Guerrero T, Mayordomo C, et al. on behalf of the EOLO Study Group. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. Respiration 2000; 67: 495-501
4. Garibaldi RA. Epidemiology of community acquired respiratory tract infections in adults: Incidence, etiology and impact. Am J Med 1995; 78: 32-7
5. Burrows B, Earle RH. Course and prognosis of chronic obstructive lung disease: a prospective study of 200 patients. N Engl J Med 1969; 280: 397-404
6. Miravitlles M, Murio C, Guerrero T, et al. for the DAFNE Study Group. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002; 121 (5): 1449-55
7. Skrepnek GH, Skrepnek SV. Epidemiology, clinical and economic burden, and natural history of chronic obstructive pulmonary disease and asthma. Am J Manag Care 2004; 10: S129-38
8. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health related quality of life. Ann Intern Med 1997; 127: 1072-9
9. Schlenk EA, Erlen JA, Dunbar-Jacob J, et al. Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res 1998; 7: 57-65
10. Moody L, McCormick K, Williams AR. Psychophysiologic correlates of quality of life in chronic bronchitis and emphysema. West J Nurs Res 1991; 13: 336-62
11. Curtis JR, Deyo RA, Hudson LD. Health-related quality of life among patients with chronic obstructive pulmonary disease. Thorax 1994; 49: 162-70
12. Fletcher C, Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-8
13. Miravitlles M, Ferrer M, Pont A, et al. for the IMPACT study group. Exacerbations impair quality of life in patients with chronic obstructive pulmonary disease: a two-year follow-up study. Thorax 2004; 59: 387-95
14. Nicolson P, Anderson P. The patient's burden: physical and psychological effects of acute exacerbations of chronic bronchitis. J Antimicrob Chemother 2000; 45: 25-32
15. Lehnert H, Schuster H-P. Innere medizin. Stuttgart: Ferdinand Enke Verlag, 1998
16. 1 decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 358-64
17. Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002; 57: 847-52
18. Curtis JR, Martin DP, Martin TR. Patient-assessed health outcomes in chronic lung disease: what are they, how do they help us, and where do we go from here? Am J Respir Crit Care Med 1997; 156: 1032-9
19. Ketelaars CAJ, Schlosser MAG, Mostert RT, et al. Determinants of health-related quality of life in patients with chronic obstructive pulmonary disease. Thorax 1996; 51: 39-43
20. Jones PW, Bosh TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-9
21. McSweeney AJ, Heaton RK, Grant I, et al. Chronic obstructive pulmonary disease: socioemotional adjustment and quality of life. Chest 1982; 77: 309-11
22. Okubadejo AA, Jones PW, Wedzicha JA. Quality of life in patients with chronic obstructive pulmonary disease and severe hypoxemia. Thorax 1996; 51: 44-7
23. Aaron SD, Vandemheen KL, Hebert P, et al. Outpatient oral prednisone after emergency treatment of chronic obstructive pulmonary disease. N Engl J Med 2003; 348: 2618-25
24. Aaron SD, Vandemheen KL, Clinch JJ, et al. Measurement of short-term changes in dyspnoea and disease-specific quality of life following an acute COPD exacerbation. Chest 2002; 121 (3): 688-96
25. Almagro P, Calbo E, de Echagüen AO, et al. Mortality after hospitalisation for COPD. Chest 2002; 121: 1441-8
26. Andersson I, Johansson K, Larsson S, et al. Long-term oxygen therapy and quality of life in elderly patients hospitalised due to severe exacerbation of COPD: a 1 year follow-up study. Respir Med 2002; 96: 944-9
27. Anie K, Lowton K, Jones PW. Changes in health status following an acute infective exacerbation of COPD [abstract]. Eur Respir J 1997; 10: 148S
28. Behnke M, Taube C, Kirsten D, et al. Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med 2000; 94: 1184-91
29. Connors AF, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 959-67
30. Davies L, Wilkinson M, Bonner S, et al. "Hospital at home" versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. BMJ 2000; 321: 1265-8
31. Dellamonica P, Reman A, Chiche D, et al. Traitement des exacerbations des bronchitis chroniques: céfuroxime IM avec relais per os par céfuroxime axetil versus ceftriaxone IM. Med Mal Infect 1997; 27: 294-300
32. Doll H, Grey-Amante P, Duprat-Lomon I, et al. Quality of life in acute exacerbation of chronic bronchitis: results from a German population study. Respir Med 2002; 96: 39-51
33. Doll H, Duprat-Lomon I, Ammerman E, et al. Validity of the St George's respiratory questionnaire at acute exacerbation of chronic bronchitis: comparison with the Nottingham health profile. Qual Life Res 2003; 12: 117-32
34. Garcia-Aymerich J, Farrero E, Félez MA, et al. Risk factors of re-admission to hospital for a COPD exacerbation: a prospective study. Thorax 2003; 58: 100-5
35. Grossman R, Mukherjee J, Vaughan D, et al. for the Canadian Ciprofloxacin Health Economic Study Group. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. Chest 1998; 113 (7): 131-41
36. Lorenz J, Thate-Waschke IM, Mast O, et al. Treatment outcomes in acute exacerbations of chronic bronchitis: comparison of macrolides and moxifloxacin from the patient perspective. J Int Med Res 2001; 29: 74-86
37. Lynn J, Ely W, Zhong Z, et al. Living and dying with chronic obstructive pulmonary disease. J Am Geriatr Soc 2000; 48: S91-S100
38. Osman LM, Godden DJ, Friend JAR, et al. Quality of life and hospital re-admission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52: 67-71
39. Patterson C, Langan CE, McKaig GA, et al. Assessing patient outcomes in acute exacerbation of chronic bronchitis: the measure your medical outcome profile (MYMOP), medical outcomes study 6-item general health survey (MOS-6A) and EuroQoL (EQ-5D). Qual Life Res 2000; 9: 521-7
40. Saundy-Unterberger H, Martin JG, Gray-Donald K. Impact of nutritional support on functional status during an acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1997; 156: 794-9
41. Schouenborg P, Gerdes N, Rasmussen HH, et al. Azithromycin versus pivampicillin in the treatment of acute exacerbations of chronic bronchitis: a single-blind, double-dummy, multicentre study. J Int Med Res 2000; 28: 101-10
42. Seneff MG, Wagner DP, Wagner RP, et al. Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease. JAMA 1995; 274: 1852-7
43. Spencer S, Jones PW, for the GLOBE Study Group. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003; 58: 589-93
44. Bach PB, Brown C, Gelfand SE, et al. Management of acute exacerbations of chronic obstructive pulmonary disease: a summary and appraisal of published evidence. Ann Intern Med 2001; 134 (7): 600-20
45. Blanchard AR. Treatment of COPD exacerbations: pharmacologic options and modification of risk factors. Postgrad Med 2002; 111 (6): 65-8, 71-2, 75
46. Calverley PMA. Modern treatment of chronic obstructive pulmonary disease. Eur Respir J 2001; 18 Suppl. 34: 60S-6S
47. Camargo CA. The relationship between COPD exacerbations and other outcomes. Eur Respir Rev 2002; 12: 9-10
48. Morris S, Anderson P, Irwin DE. Acute exacerbations of chronic bronchitis: a pharmacoeconomic review of antibacterial use. Pharmacoeconomics 2002; 20 (3): 153-68
49. Perfetto EM, Mullins CD, Subedi P, et al. Selection of clinical, patient-reported, and economic end points in acute exacerbation of chronic bronchitis. Clin Ther 2001; 23 (10): 1747-72
50. Sohy C, Pilette C, Niederman MS, et al. Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed? Eur Respir J 2002; 19: 966-75
51. Jones PW, Quirk FH, Baveystock CM, et al. A self-complete measure of health status for chronic airflow limitation: the St George's Respiratory Questionnaire. Respir Med 1991; 85: 25-31
52. Jones PW. Interpreting thresholds for a clinically significant change in health status in asthma and COPD. Eur Respir J 2002; 19: 398-404
53. Jaeschke R, Singer J, Guyatt GH. Measurement of health status ascertaining the minimal clinically important difference. Control Clin Trials 1989; 10: 407-15
54. Peach H, Pathy MS. Follow-up study of disability among elderly patients discharged from hospital with exacerbations of chronic bronchitis. Thorax 1981; 36: 585-9
55. Wu AW, Damiano AM, Lynn J, et al. Predicting future functional status for seriously ill hospitalised adults. The SUPPORT prognostic model. Ann Intern Med 1995; 122: 342-50
56. Smucny JJ, Becker LA, Glazier RH, et al. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998; 47: 453-60
57. Leidy NK, Margolis MK, Anton SF, et al. Health-related quality of life effects and outcomes of treatment in patients with COPD. Eur Respir Rev 2002; 12: 83, 79-86
58. Bowling A. Measuring disease: a review of disease specific quality of life measurement scales. Philadelphia (PA): Open University Press, 149-74, 2001
59. Chen Y, Breithaupt K, Muhajarine N. Occurrence of chronic obstructive pulmonary disease among Canadians and sex-related risk factors. J Clin Epidemiol 2000; 53: 755-61
60. Del Donno M, Olivieri D. Mucoactive drugs in the management of chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 1998 Dec; 53 (6): 714-9
61. DiLorenzo G, Morici G, Drago A, et al. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. Clin Ther 1998; 20: 1130-48
62. Fishman AP. Pulmonary rehabilitation research. Am J Crit Care Med 1994; 149: 825-33
63. Morgan MDL. Experience of using the CRQ (Chronic Respiratory Questionnaire). Respir Med 1991; 85 Suppl. B: 23-4
64. Taytard A, Cousson F. Symptoms and life of patients with chronic bronchitis: preliminary results. Rev Pneumol Clin 1996; 52 (6): 379-85
65. Maille AR, Koning CJ, Zwinderman AH, et al. The development of the Quality of Life for Respiratory Illness Questionnaire (QoL-RIQ): a disease-specific quality of life questionnaire for patients with mild to moderate chronic non-specific lung disease. Respir Med 1997 May; 91 (5): 297-309
66. Miravitlles M, Alvarez-Sala JL, Lamarca R, et al. for the IMPAC Study Group. Treatment and quality of life in patients with chronic obstructive pulmonary disease. Qual Life Res 2002; 11: 329-38
67. Tsukino M, Nishimura K, Ikeda A, et al. Physiologic factors that determine the health-related quality of life in patients with COPD. Chest 1996; 111 (4): 896-903
68. Seemungal TAR, Donaldson GC, Bhowmik A, et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608-13
69. Niewoehner DE, Collins D, Erbland ML. Relation of FEV(1) to clinical outcomes during exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. Am J Respir Crit Care Med 2000; 161: 1201-5
70. Yohannes AM, Roomi J, Waters K, et al. Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med 1998; 92: 1231-6
71. Wegner RA, Jörres RA, Kirsten DK, et al. Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD. Eur Respir J 1994; 7: 725-9
72. Hajiro T, Nishimura K, Tsukino M, et al. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 1185-9
73. Jones PW. Health status measurement in COPD. Thorax 2001; 56: 880-7
74. Bmsasco V, Hodder R, Miravitlles M, et al. Health outcomes following six months treatment with once daily tiotropium compared to twice daily salmeterol in patients with COPD. Thorax 2003; 58: 399-404
75. Barr JT, Schumacher GE, Freeman S, et al. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000; 22: 1121-45
76. Rutten-van Mölken M, Roos B, Van Noord JA. An empirical comparison of the St. George's Respiratory Questionnaire (SGRQ) and the Chronic Respiratory Disease Questionnaire (CRQ) in a clinical trial setting. Thorax 1999; 54: 995-1003
77. Grossman RF. How do we achieve cost-effective options in lower respiratory tract infection therapy? Chest 1998; 113 (3S): 205S-10S
78. Wilson R, Wilson C. Defining subsets of patients with chronic bronchitis. Chest 1997; 112: 303S-9S
79. Adams SG, Melo J, Luther M, et al. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 2000; 117 (5): 1345-52
80. Miravitlles M. Designing future clinical trials for acute exacerbations of chronic bronchitis. In: Allegra L, Blasi F, editors. Mechanisms and management of COPD exacerbations. Milano: Springer-Verlag, 2000: 88-99
81. Perkins HS. Using outcome predictions to make treatment decisions. Chest 1987; 91: 475-6
82. Menzies R, Gibbons W, Goldberg P. Determinants of weaning and survival among patient with COPD who require mechanical ventilation for acute respiratory failure. Chest 1989; 95: 398-405
83. Örtqvist A. Treatment of community-acquired lower respiratory tract infections in adults. Eur Respir J 2002; 20 (36S): 40S-53S
84. Snow V, Lascher S, Mottur-Pilson C. The evidence base for management of acute exacerbations of COPD. Chest 2001; 119: 1185-9
85. White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease 6: the aetiology of exacerbations of chronic obstructive pulmonary disease. Thorax 2003; 58: 73-80
86. Anthonisen NR, Manfreda J, Warren CP, et al. Antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease. Ann Intern Med 1987; 106: 196-204
87. Wilson R, Grossman R. Introduction: the role of bacterial infection in chronic bronchitis. Semin Respir Infect 2000; 15 (1): 1-6
88. Miravitlles M. Epidemiology of chronic obstructive pulmonary disease exacerbations. Clin Pulm Med 2002; 9 (4): 1-7
89. Miravitlles M, Murio C, Guerrero T, et al. on behalf of the DAFNE study group. Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. Eur Respir J 2001; 17: 928-33
90. Asmundsson T, Kilburn KH. Survival after acute respiratory failure: 145 patients observed 5 to 8 and one-half years. Ann Intern Med 1974; 80: 54-7
91. Burk RH, George RB. Acute respiratory failure in chronic obstructive pulmonary disease: immediate and long-term prognosis. Arch Intern Med 1973; 132: 865-8
92. Sluiter HJ, Blokzijl EJ, van Dijl W, et al. Conservative and respirator treatment of acute respiratory insufficiency in patients with chronic obstructive lung disease: a reappraisal. Am Rev Respir Dis 1972; 105: 932-43
93. Teno JM, Harrell FE, Knaus W, et al. Prediction of survival for older hospitalised patients: the HELP survival model. J Am Geriatr Soc 2000; 48 (5 Suppl.): S16-24
94. Vandenbergh E, van de Woestlijne KP, Gyslen A. Conservative treatment of acute respiratory failure in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis 1968; 98: 60-9
95. Warren PM, Millar JS, Fenley DC, et al. Respiratory failure revisited: acute exacerbations of chronic bronchitis between 1961-1968 and 1970-1976. Lancet 1980; 1: 467-71
96. Read RC. Infection in acute exacerbations of chronic bronchitis: a clinical perspective. Respir Med 1999; 93: 845-50
97. Adams SG, Anzueto A. Antibiotic therapy in acute exacerbations of chronic bronchitis. Semin Respir Infect 2000; 15 (3): 234-47
98. McCrory DC, Brown C, Gelfand SE, et al. Management of acute exacerbations of COPD. Chest 2001; 119: 1190-209
99. Niederman MS. Antibiotic therapy of exacerbations of chronic bronchitis. Semin Respir Infect 2000; 15 (1): 59-70
100. Saint S, Bent S, Vittinghoff E, et al. Antibiotics in chronic pulmonary disease exacerbations: a meta-analysis. JAMA 1995; 273: 957-60
101. Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: factors associated with poor treatment outcome. Chest 2000; 117: 662-71
102. Rowe BH, Oxman AD. Performance of an asthma quality of life questionnaire in an outpatient setting. Am Rev Respir Dis 1993; 148: 675-81
103. Kanga J, Kühn R, Craigmyle L, et al. Cystic fibrosis clinical score: a new scoring system to evaluate acute pulmonary exacerbation. Clin Ther 1999; 21 (8): 1343-56
104. Evans AT, Husain S, Durairaj L, et al. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002; 359: 1648-54
105. Yohannes AM, Hardy CC. Treatment of chronic obstructive pulmonary disease in older patients: a practical guide. Drugs Aging 2003; 20: 209-28